A device that targets rapidly growing cancer cells with low frequency (100-300 kHz) alternating electric fields, called Tumor-Treating Fields (TTFields), doubled the survival rates of patients with brain cancer, according to a Proceedings of the National Academy of Sciences (PNAS) journal article.